We are live on
!
Find out more
BRA
Biechele Royce Advisors Portfolio holdings
AUM
$303M
1-Year Est. Return
20.64%
This Fund
S&P 500
This Quarter
Est. Return
-2.05%
1 Year Est. Return
+20.64%
3 Year Est. Return
+39.24%
5 Year Est. Return
+125.34%
10 Year Est. Return
–
AUM
$271M
AUM Growth
-$15.9M
(-5.5%)
Cap. Flow
-$7.58M
Cap. Flow
% of AUM
-2.8%
Top 10 Holdings %
Top 10 Hldgs %
55.72%
Holding
72
New
2
Increased
21
Reduced
33
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.59M |
| 2 |
Robert Half
RHI
|
+$1.16M |
| 3 |
Medtronic
MDT
|
+$743K |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$678K |
| 5 |
United Parcel Service
UPS
|
+$524K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.76M |
| 2 |
BorgWarner
BWA
|
+$1.75M |
| 3 |
Airbnb
ABNB
|
+$840K |
| 4 |
MSC Industrial Direct
MSM
|
+$600K |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$518K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.93% |
| 2 | Industrials | 20.41% |
| 3 | Healthcare | 20.01% |
| 4 | Financials | 11.71% |
| 5 | Consumer Discretionary | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Applied Materials
AMAT
$410B
| $20.9M | 7.69% |
150,754
-2,574
| -2% | -$369K |
|
2
Apple
AAPL
$4.95T
| $19.5M | 7.2% |
114,036
-1,612
| -1% | -$296K |
|
3
Amgen
AMGN
$203B
| $17.7M | 6.54% |
66,002
-12
| -0% | -$3K |
|
|
4
BorgWarner
BWA
$13.1B
| $14.9M | 5.48% |
368,107
-41,337
| -10% | -$1.75M |
|
|
5
Robert Half
RHI
$4.07B
| $14.2M | 5.22% |
193,321
+15,241
| +9% | +$1.16M |
|
6
CVS Health
CVS
$137B
| $13.4M | 4.95% |
192,269
+6,232
| +3% | +$442K |
|
7
ON Semiconductor
ON
$34.7B
| $13.2M | 4.87% |
142,137
-2,923
| -2% | -$284K |
|
|
8
United Parcel Service
UPS
$96B
| $13M | 4.8% |
83,539
+3,033
| +4% | +$524K |
|
|
9
Medtronic
MDT
$108B
| $12.8M | 4.71% |
163,005
+8,876
| +6% | +$743K |
|
|
BNY
10
Bank of New York Mellon
BNY
$107B
| $11.5M | 4.26% |
270,775
+15,227
| +6% | +$678K |
|
11
Franklin Resources
BEN
$17.3B
| $10.6M | 3.92% |
432,622
-10,253
| -2% | -$277K |
|
12
iShares Silver Trust
SLV
$28.3B
| $10.4M | 3.84% |
512,088
-5,034
| -1% | -$109K |
|
13
Pentair
PNR
$10.2B
| $9.98M | 3.68% |
154,098
-1,350
| -0.9% | -$90.9K |
|
14
Intel
INTC
$462B
| $9.07M | 3.34% |
255,034
-1,623
| -0.6% | -$56.5K |
|
|
15
MSC Industrial Direct
MSM
$7.07B
| $9.03M | 3.33% |
91,976
-6,076
| -6% | -$600K |
|
16
Nucor
NUE
$56.4B
| $8.45M | 3.12% |
54,052
-1,389
| -3% | -$230K |
|
|
SCHW
17
Charles Schwab
SCHW
$181B
| $7.9M | 2.91% |
143,887
+26,298
| +22% | +$1.59M |
|
18
Caterpillar
CAT
$402B
| $6.01M | 2.22% |
22,015
-391
| -2% | -$106K |
|
19
Zimmer Biomet
ZBH
$17.8B
| $5.9M | 2.17% |
52,536
-587
| -1% | -$74.5K |
|
20
SLB Ltd
SLB
$76.5B
| $5.75M | 2.12% |
98,537
-1,056
| -1% | -$61.2K |
|
21
Eli Lilly
LLY
$1.07T
| $4.2M | 1.55% |
7,827
+39
| +0.5% | +$20.1K |
|
22
Warner Bros
WBD
$63.4B
| $3.63M | 1.34% |
333,856
-1,269
| -0.4% | -$15.8K |
|
|
K
23
DELISTED
Kellanova
K
| $2.89M | 1.07% |
51,773
-2,296
| -4% | -$137K |
|
24
AT&T
T
$167B
| $2.22M | 0.82% |
147,558
-10,851
| -7% | -$159K |
|
|
25
Airbnb
ABNB
$87.2B
| $1.95M | 0.72% |
14,240
-6,082
| -30% | -$840K |
|
Similar funds
S
OHCM
E
CHA
BFA
IF
BWM
T
Biechele Royce Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Biechele Royce Advisors held 72 positions worth $271M, down 5.5% from $287M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Biechele Royce Advisors's Q3 2023 filing shows 2 new, 21 increased, 33 reduced and 7 closed positions. Its largest new stake was Vanguard Ultra-Short Bond ETF: 8,100 shares worth $398K. The largest sale was Bristol-Myers Squibb, an estimated $6.76M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.
- Biechele Royce Advisors's largest Q3 2023 buy was Vanguard Ultra-Short Bond ETF: 8,100 shares worth $398K.
- Biechele Royce Advisors added most to Charles Schwab in Q3 2023, an estimated $1.59M increase.
- Biechele Royce Advisors's biggest Q3 2023 reduction was BorgWarner, cutting an estimated $1.75M.
- Biechele Royce Advisors fully exited Bristol-Myers Squibb in Q3 2023, selling an estimated $6.76M.
- Biechele Royce Advisors's ten largest holdings make up 56% of its $271M portfolio in Q3 2023.
- Biechele Royce Advisors opened 2 new positions and closed 7 in Q3 2023.
- Biechele Royce Advisors's portfolio value fell 5.5% quarter-over-quarter to $271M.
Based on Biechele Royce Advisors's 13F filing for Q3 2023, filed 1 Nov 2023.